Chemomab Therapeutics Ltd (CMMB)
0.631
-0.03
(-4.25%)
USD |
NASDAQ |
Apr 26, 13:42
Chemomab Therapeutics Total Liabilities (Quarterly): 6.858M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 6.858M |
| March 31, 2023 | 7.059M |
| December 31, 2022 | 6.84M |
| September 30, 2022 | 5.595M |
| June 30, 2022 | 4.542M |
| March 31, 2022 | 3.72M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.887M |
| September 30, 2021 | 1.928M |
| June 30, 2021 | 2.479M |
| March 31, 2021 | 4.959M |
| December 31, 2020 | 1.674M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.674M
Minimum
Dec 2020
7.059M
Maximum
Mar 2023
4.413M
Average
4.542M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd | 55.78M |
| Pluri Inc | 34.95M |
| BioLine Rx Ltd | 50.70M |
| Can Fite Biofarma Ltd | 3.746M |
| BiomX Inc | 21.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.85M |
| Shareholders Equity (Quarterly) | 21.99M |